List of medications

List of medications, May 25, 2023
- Ministerial order – List of medications, May 25, 2023

Regulation respecting the List of medications covered by the basic prescription drug insurance plan (CQLR, chapter A-29.01, r. 3)

The List of medications constitutes a regulatory list of the medications covered by Québec’s basic prescription drug insurance plan. See list update schedule.

For previous versions of the list, see the register below. The "Related legal document" links point to the minister’s orders and RAMQ notices pertaining to the list.

Please note that under the seventh paragraph of section 60 and section 60.1 of the Act respecting prescription drug insurance (CQLR, chapter A-29.01), publication on this website of a regulation respecting the List of medications and of the Related legal documents imparts authentic value to them.

Notices of end of coverage

No notice of end of coverage

Notices of exclusion

No notice of exclusion

Notices of replacement

Notice of alternative medication authorization, May 10, 2023:
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
Notice of alternative medication authorization, May 5, 2023 – Hydroxyzine hydrochloride replaces:
- Hydroxyzine
- Teva-Hydroxyzin
Notice of alternative medication authorization, April 28, 2023 – Cyclopentolate hydrochloride replaces:
- Cyclogil
- Odan-Cyclopentolate
Notice of alternative medication authorization, April 28, 2023 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, April 20, 2023 – Clindamycin phosphate replaces Taro-Clindamycin
Notice of alternative medication authorization, April 13, 2023 – Prednisolone acetate replaces:
- Ratio-Prednisolone
- Sandoz Prednisolone
Notice of alternative medication authorization, April 13, 2023 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, March 30 2023 – Quinapril hydrochloride 5 mg, 10 mg, 20 mg et 40 mg replace:
- Accupril
- Apo-Quinapril
- pms-Quinapril
Notice of alternative medication authorization, March 14, 2023 – Thiamine hydrochloride replaces Thiamiject
Notice of alternative medication authorization, March 9, 2023 – Minoxidil replaces Loniten

Notice of alternative medication authorization, May 10, 2023:
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
Notice of alternative medication authorization, May 5, 2023 – Hydroxyzine hydrochloride replaces:
- Hydroxyzine
- Teva-Hydroxyzin
Notice of alternative medication authorization, April 28, 2023 – Cyclopentolate hydrochloride replaces:
- Cyclogil
- Odan-Cyclopentolate
Notice of alternative medication authorization, April 28, 2023 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, April 20, 2023 – Clindamycin phosphate replaces Taro-Clindamycin
Notice of alternative medication authorization, April 13, 2023 – Prednisolone acetate replaces:
- Ratio-Prednisolone
- Sandoz Prednisolone
Notice of alternative medication authorization, April 13, 2023 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, March 30 2023 – Quinapril hydrochloride 5 mg, 10 mg, 20 mg et 40 mg replace:
- Accupril
- Apo-Quinapril
- pms-Quinapril
Notice of alternative medication authorization, March 14, 2023 – Thiamine hydrochloride replaces Thiamiject
Notice of alternative medication authorization, March 9, 2023 – Minoxidil replaces Loniten
Notice of alternative medication authorization, December 28, 2022 – Propranolol hydrochloride replaces Teva-Propranolol
Notice of alternative medication authorization, February 28, 2023 – Hydroxyzine hydrochloride rempaces:
- Hydroxyzine
- Novo-Hydroxyzin
Notice of alternative medication authorization, February 27, 2023 – Ergocalciferol replaces Jamp-D2-Dol
Notice of alternative medication authorization, February 16, 2023 – Imipenem/Cilastatin sodium replaces Taro-Imipenem-Cilastatin
Notice of alternative medication authorization, February 16, 2023:
- Prazosin hydrochloride 1 mg remplace Teva-Prazosin 1 mg
- Prazosin hydrochloride 2 mg remplace Teva-Prazosin 2 mg
- Prazosin hydrochloride 5 mg remplace Teva-Prazosin 5 mg
Notice of alternative medication authorization, January 30, 2023 – Folic acid replaces:
- Euro-Folic
- Jamp-Folic Acid
Notice of alternative medication authorization, January 5, 2023 – Furosemide replaces Lasix Special
Notice of alternative medication authorization, January 4, 2023 – Gentamicin sulfate replaces Gentamicin Injection
Notice of alternative medication authorization, December 6, 2022 – Nifedipine replaces Nifedipine
Notice of alternative medication authorization, November 7, 2022 – Amoxicillin replaces:
- Amoxicillin
- Apo-Amoxi
- Auro-Amoxicillin
- Novamoxin
- Novamoxin-250
- pms-Amoxicillin
- Pro-Amox-250

Notice of alternative medication authorization, December 28, 2022 – Rifampin 150 mg et 300 mg replace:
- Rofact 150
- Rofact 300
Notice of alternative medication authorization, December 16, 2022 – Codeine phosphate, 25 mg/5 ml, Syr. replaces Codeine
Notice of alternative medication authorization, December 16, 2022 – Codeine phosphate, 30 mg, Caps. replaces:
- Codeine
- Teva-Codeine
Notice of alternative medication authorization, December 13, 2022 – Propranolol hydrochloride replaces Teva-Propranolol
Notice of alternative medication authorization, December 6, 2022 – Heparine sodium replaces Heparin sodium injection, USP
Notice of alternative medication authorization, December 6, 2022 – Heparine sodium replaces Heparin sodium injection, USP
Notice of alternative medication authorization, December 6, 2022 – Nifedipine replaces Nifedipine
Notice of alternative medication authorization, December 2, 2022 – Acetylcysteine solution replaces Acetylcysteine
Notice of alternative medication authorization, December 1, 2022 – Minoxidil replaces Loniten
Notice of alternative medication authorization, November 24, 2022 – Amoxicillin/Potassium clavulanate replaces Clavulin-400
Notice of alternative medication authorization, October 14, 2022 – Haloperidol replaces Teva-Haloperidol
Notice of alternative medication authorization, November 15, 2022 – Spironolactone replaces:
- Jamp Spironolactone
- Mint-Spironolactone
- Teva-Spironolactone
Notice of alternative medication authorization, November 7, 2022 – Quinine sulfate replaces:
- Jamp-Quinine
- Novo-Quinine
- Pro-Quinine-200
- Quinine-Odan (Caps.)
Notice of alternative medication authorization, November 3, 2022 – Atropine sulfate replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, November 16, 2022 – Diphenhydramine (chlorhydrate de) replaces Diphenhydramine (chlorhydrate de)
Notice of alternative medication authorization, October 31, 2022 – Spironolactone replaces:
- Jamp Spironolactone
- Mint-Spironolactone
- Teva-Spironolactone
Notice of alternative medication authorization, October 28, 2022 – Ibuprofene replaces Europrofen
Notice of alternative medication authorization, October 24, 2022 – Estradiol-17B replaces Estrogel
Notice of alternative medication authorization, October 24, 2022 – Prochlorperazine replaces Sandoz Prochloperazine
Notice of alternative medication authorization, September 2, 2022 – Sulfasalazine replaces Pms-Sulfasalazine-E.C
Notice of alternative medication authorization, October 14, 2022 – Haloperidol replaces Teva-Haloperidol
Notice of alternative medication authorization, October 17, 2022 – Acetaminophene replace:
- Jamp-Acetaminophene
- Pediatrix
Notice of alternative medication authorization, October 13, 2022 – Betamethasone valerate replaces Betaderm Taro
Notice of alternative medication authorization, October 7, 2022 – Oxycodone hydrochloride 10 mg and 20 mg replace Supeudol Sandoz
Notice of alternative medication authorization, October 5, 2022 – Amoxicillin/Potassium clavulanate replaces GSK Clavulin-400
Notice of alternative medication authorization, September 16, 2022 – Penicillin G Sodium replaces Penicillin G
Notice of alternative medication authorization, August 22, 2022 – Heparin sodium replaces Heparin sodium injection, USP
Notice of alternative medication authorization, August 18, 2022 – Electrolyte replacement/dextrose replace:
- Gastrolyte
- Jamp Rehydralyte
Notice of alternative medication authorization, August 16, 2022 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, August 16, 2022 – Trifluoperazine hydrochloride (5 mg – Caps.), Trifluoperazine hydrochloride (10 mg – Caps.), and Trifluoperazine hydrochloride (20 mg – Caps.) replace:
- Trifluoperazine hydrochloride (5 mg – Tab.)
- Trifluoperazine hydrochloride (10 mg – Tab.)
- Trifluoperazine hydrochloride (20 mg – Tab.)
Notice of alternative medication authorization, August 8, 2022 – Hydroxyzine hydrochloride replaces:
- Hydroxyrine
- Novo-Hydroxyzin
Notice of alternative medication authorization, August 8, 2022 – Acetaminophen (160 mg/5 ml – Liq.), and Acetaminophen (160 mg/5 ml – Liq.) replace:
- Acetaminophen
- Jamp-Acetaminophen
- PDP-Acetaminophen solution
Notice of alternative medication authorization, July 29, 2022 – Diphenhydramine hydrochloride replaces Diphenhydramine hydrochloride
Notice of alternative medication authorization, July 18, 2022 – Nutritional formula – infants and children (Althéra UK) and Nutritional formula – infants and children (Alfamino UK) replace:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, July 11, 2022 – Tocilizumab (162 mg/0.9 ml (4 ml)), Tocilizumab (162 mg/0.9 ml (10 ml)) and Tocilizumab (162 mg/0.9 ml (20 ml)) replace:
- Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (syr)
- Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (pen)
Notice of alternative medication authorization, June 27, 2022 – Nutritional formula – infants and children (Similac Alimentum US 946 ml) replaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, June 17, 2022 – Diazapam replaces:
- Diastat 1 ml (5 mg)
- Diastat 2 ml (10 mg)
Notice of alternative medication authorization, June 17, 2022 – Imipenem/Cilastatin sodium replaces Primaxin
Notice of alternative medication authorization, June 17, 2022 – Hydrocortisone replaces Cortef
Notice of alternative medication authorization, June 15, 2022 – Minoxidil replaces Loniten
Notice of alternative medication authorization, June 14, 2022 – Nutritional formula – infants and children (Nestlé Gerber Good Start Extensive HS – imported) remplaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, June 10, 2022 – Insulin lispro replaces Admelog SanofiAven
Notice of alternative medication authorization, May 31, 2022 – Nutritional formula – infants and children (Nutramigen A+ concentrated – imported) rempaces:
- Alimentum
- Nutramigen A+
- Pregestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, May 26, 2022 – Terbutatine sulfate replaces Bricanyl Turbuhaler
Notice of alternative medication authorization, May 18, 2022 – Octreotide acetate (99113996) replaces Sandostatin
Notice of alternative medication authorization, May 17, 2022 – Minoxidil (99113991) replaces Loniten
Notice of alternative medication authorization, May 17, 2022 – Minoxidil (99113992) replaces Loniten
Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate replaces Florinef
Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate (99113993) replaces Florinef
Notice of alternative medication authorization, May 16, 2022 – Fludrocortisone acetate (99113994) replaces Florinef
Notice of alternative medication authorization, May 4, 2022 – Octreotide acetate (99113995) replaces Sandostatin
Notice of alternative medication authorization, May 1, 2022 – Nutritional formula - casein Hydrolysate(infants and children) replaces:
- Alimentum
- NutramigenA+
- Presgestimil A+
- Nutramigen A+ LGG
Notice of alternative medication authorization, March 30, 2022 – Sodium phosphate monobasic / Sodium phosphate dibasic replaces Lax-A NEMA
Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113958) replaces:
- Taro-Carbamazepine
- Tegretol
Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113955) replaces:
- Taro-Carbamazepine
- Tegretol
Notice of alternative medication authorization, January 21, 2022 – carbamazepine (99113954) replaces:
- Taro-Carbamazepine
- Tegretol
Notice of alternative medication autorization, January 21, 2022 – hydrocortisone replaces Sandoz Hydrocortisone

Notice of alternative medication authorization, December 16, 2021 – Medroxyprogesterone acetate (99113945) replaces Apo-Medroxy
Notice of alternative medication authorization, December 7, 2021 – Progesterone replaces ACT Progesteron Injection
Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113940) replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113939) replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, December 2, 2021 – Medroxyprogesterone acetate (99113938) replaces:
- Apo-Medroxy
- Novo-Medrone
- Provera
Notice of alternative medication authorization, December 2, 2021 – Sulfasalazine replaces pms-Sulfasalazine
Notice of alternative medication authorization, November 30, 2021 – Famatidine replaces Novo-Famotidine
Notice of alternative medication authorization, November 25, 2021 – Medroxyprogesterone acetate (99113947) replaces
- Apo-Medroxy
- Novo-Medroxy
Notice of alternative medication authorization, November 25, 2021 – Medroxyprogesterone acetate (99113937) replaces :
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, November 25, 2021 – Medroxyprogestérone acetate (99113933) replaces:
- Apo-Medroxy
- Novo-Medrone
Notice of alternative medication authorization, August 20, 2021 – Estrone replaces Estragyn vaginal cream
Notice of alternative medication authorization, July 8, 2021 – Metroxyprogesterone acetate replaces Depo-Provera
Notice of alternative medication authorization, May 28, 2021 – Atropine sulfate 5 ml replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, May 28, 2021 – Atropine sulfate 0.5 ml replaces:
- Atropine
- Isopto Atropine
Notice of alternative medication authorization, May 20, 2021 – Phenelzine sulfate replaces Phenelzine sulfate
Notice of alternative medication authorization, May 19, 2021 – Trifluoperazine hydrochlorhide replaces Trifluoperazine
Notice of alternative medication authorization, May 18, 2021 – Sodium chloride replaces Nebusal 7%
Notice of alternative medication authorization, May 11, 2021 – Bacitracine replaces Bacitracin
Notice of alternative medication authorization, April 13, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
Notice of alternative medication authorization, April 6, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
Notice of alternative medication authorization, April 6, 2021 – Pindolol replaces:
- Apo-Pindol
- Novo-Pindol
- Visken
Notice of alternative medication authorization, March 12, 2021 – Sodium phosphate monobasic and dibasic replaces:
- Fleet
- Lax-A NEMA
Notice of alternative medication authorization, February 18, 2021 – Ibuprofen replaces Europrofen
Notice of alternative medication authorization, February 18, 2021 – Metoprolol tartrate replaces:
- Lopresor SR
- Metoprolol SR
- Sandoz Metoprolol SR
Notice of alternative medication authorization, February 9, 2021 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, February 2, 2021 – Trifluoperazine hydrochloride replaces Trifluoperazine
Notice of alternative medication authorization, January 15, 2021 – Hydromorphone hydrochloride replaces pms-Hydromorphone
Notice of alternative medication authorization, January 8, 2021 – Nicoumalone replaces Sintrom

Notice of alternative medication authorization, December 8, 2020 – Acyclovir sodium replaces:
- Acyclovir Sodique
- Acyclovir sodique injectable
Notice of alternative medication authorization, October 27, 2020 – Spironolactone replaces:
- Mint-Spironolactone
- Teva-Spironolactone
Notice of alternative medication authorization, October 26, 2020 – fluvastatine sodium replaces:
- Sandoz Fluvastatin
- Teva Fluvastatin
Notice of alternative medication authorization, October 26, 2020 – Fluvastatine sodium replaces Teva Fluvastatin
Notice of alternative medication authorization, October 19, 2020 – Manerix replaces moclobemid
Notice of alternative medication authorization, October 19, 2020 – Manerix replaces moclobemid
Notice of alternative medication authorization, September 25, 2020 – Palbociclib replaces Ibrance
Notice of alternative medication authorization, September 25, 2020 – Palbociclib replaces Ibrance
Notice of alternative medication authorization, September 25, 2020 – Palbociclib replaces Ibrance
Notice of alternative medication authorization, September 21, 2020 – Buprenorphine replaces Sublocade
Notice of alternative medication authorization, September 21, 2020 – Buprenorphine replaces Sublocade
Notice of alternative medication authorization, July 16, 2020 – Propylthiouracil replaces Propyl-Thyracil
Notice of alternative medication authorization, July 6, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, July 6, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, June 12, 2020 – Erythromycin replaces Erythro-Base
Notice of alternative medication authorization, June 11, 2020 – trifluoperazine hydrochloride replace Trifluoperazine
Notice of alternative medication authorization, June 2, 2020 – nystatine replaces:
- Nyaderm
- ratio-Nystatin
Notice of alternative medication authorization, May 22, 2020 – Salbutamol replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
Notice of alternative medication authorization, May 20, 2020 – Temozolomide replaces:
- ACT Temozolomide
- Taro-Temozolomide
- Temodal
Notice of alternative medication authorization, May 6, 2020 – phenelzine sulfate replaces Nardil
Notice of alternative medication authorization, May 6, 2020 – Diazepam replaces Diastat
Notice of alternative medication authorization, April 30, 2020 – Temozolomide replaces:
- Act Temozolomide
- Taro-Temozolomide
- Temodal
Notice of alternative medication authorization, April 27, 2020 – Mexiletine replaces Novo-Mexiletine
Notice of alternative medication authorization, April 24, 2020 – Ipratropium bromide replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
Notice of alternative medication authorization, April 24, 2020 – Salbutamol sulfate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
Notice of alternative medication authorization, April 24, 2020 – Formoterol fumarate dihydrate replaces:
- Airomir
- Apo-Salvent sans CFC
- Novo-Salbutamol HFA
- Salbutamol HFA
- Ventolin HFA
Notice of alternative medication authorization, April 22, 2020 – Bromocriptin mesylate replaces Bromocriptine
Notice of alternative medication authorization, April 22, 2020 – Bromocriptin mesylate replaces Bromocriptine
Notice of alternative medication authorization, April 10, 2020 – mometason furoate replaces Asmanex Twisthalerl
Notice of alternative medication authorization, April 1, 2020 – nystatine remplace :
- Jamp-Nystatin
- pms-Nystatin
- ratio-Nystatin
Notice of alternative medication authorization, March 23, 2020 – Timolol maleate replaces Sandoz Timolol
Notice of alternative medication authorization, March 6, 2020 – ethambutol hydrochloride 100 mg replaces Etibi 100 mg
Notice of alternative medication authorization, March 6, 2020 – ethambutol hydrochloride 400 mg replaces Etibi 400 mg
Notice of alternative medication authorization, March 4, 2020 – Propylthiouracil 25 mg replaces Propyl-Thyracil 50 mg
Notice of alternative medication authorization, March 4, 2020 – Propylthiouracil 50 mg replaces Propyl-Thyracil 50 mg
Notice of alternative medication authorization, March 4, 2020 – Propylthiouracil 100 mg replaces Propyl-Thyracil 100 mg
Notice of alternative medication authorization, February 26, 2020 – Prednisolone acetate replaces:
- ratio-Prednisolone
- Sandoz Prednisolone
Notice of alternative medication authorization, January 31, 2020 – Telmisartan replaces:
- Act Telmisartan
- Apo-Telmisartan
- Auro-Telmisartan
- Micardis
- pms-Telmisartan
- Sandoz Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Teva-Telmisartan
- VAN-Telmisartan
Notice of alternative medication authorization, January 31, 2020 – Telmisartan 80 mg remplace :
- Act Telmisartan
- Apo-Telmisartan
- Auro-Telmisartan
- Micardis
- pms-Telmisartan
- Sandoz Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Telmisartan
- Teva-Telmisartan
- VAN-Telmisartan
Notice of alternative medication authorization, January 21, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, January 21, 2020 – Betamethasone valerate replaces:
- Betaderm
- Celestoderm V
Notice of alternative medication authorization, January 21, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, January 20, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, January 20, 2020 – Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, January 13, 2020 – Heparin sodium replaces Heparine
Notice of alternative medication authorization, January 3, 2020 – Olmesartan medoxomil replaces:
- Act Olmesartan
- Apo-Olmesartan
- Auro-Olmesartan
- GLN-Olmesartan
- Jamp-Olmesartan
- Olmesartan
- Olmetec
- pms-Olmesartan
- Riva-Olmesartan
- Sandoz Olmesartan

Notice of alternative medication authorization, December 16, 2019 – Moclobemide 150 mg replaces Manerix 150 mg
Notice of alternative medication authorization, December 4, 2019 – Sucralfate replaces:
- Novo-Sucralate
- Sulcrate
Notice of alternative medication authorization, November 27, 2019 – Thiamine hydrochloride replaces:
- Thiamiject
- Thiamine
Notice of alternative medication authorization, November 14, 2019 – Famotidine 10 et 20 mg replaces:
- Apo-Famotidine
- Famotidine
- Novo-Famotidine
Notice of alternative medication authorization, November 14, 2019 – Famotidine 40 mg replaces:
- Apo-Famotidine
- Famotidine
- Teva-Famotidine
Notice of alternative medication authorization, November 13, 2019 – Progesterone replaces ACT Progesterone Injection
Notice of alternative medication authorization, November 8, 2019 – Tamoxifen citrate replaces:
- Apo-Tamox
- Novo-Tamoxifen
Notice of alternative medication authorization, November 5, 2019 – Olmésartan médoxomil remplaces:
- Act Olmesartan
- Apo-Olmesartan
- Auro-Olmesartan
- GLN-Olmesartan
- Jamp-Olmesartan
- Olmesartan
- Olmetec
- pms-Olmesartan
- Riva-Olmesartan
- Sandoz Olmesartan
Notice of alternative medication authorization, October 23, 2019 – Ranitidine hydrochloride replaces:
- ACT Ranitidine
- Apo-Ranitidine
- Jamp-Ranitidine
- Mar-Ranitidine
- M-Ranitidine
- pms-Ranitidine
- Ranitidine
- Ranitidine
- Ranitidine-300
- Ran-Ranitidine
- ratio-Ranitidine
- Riva-Ranitidine
- Sandoz Ranitidine
Notice of alternative medication authorization, October 17, 2019 – Ranitidine hydrochloride replaces Teva-Ranitidine Solution
Notice of alternative medication authorization, October 16, 2019 – amoxifen citrate 10 mg replaces:
- Apo-Tamox
- Novo-Tamoxifen
Notice of alternative medication authorization, October 16, 2019 – Tamoxifen citrate 20 mg replaces:
- Apo-Tamox
- Nolvadez-D
- Novo-Tamoxifen
Notice of alternative medication authorization, October 15, 2019 – Ranitidine hydrochloride replaces:
- ACT Ranitidine
- Apo-Ranitidine
- Jamp-Ranitidine
- Mar-Ranitidine
- M-Ranitidine
- pms-Ranitidine
- Ranitidine
- Ranitidine
- Ranitidine-150
- Ran-Ranitidine
- ratio-Ranitidine
- Riva-Ranitidine
- Sandoz Ranitidine
Notice of alternative medication authorization, October 15, 2019 – Ranitidine hydrochloride 150 mg replaces:
- ACT Ranitidine
- Apo-Ranitidine
- Jamp-Ranitidine
- Mar-Ranitidine
- M-Ranitidine
- pms-Ranitidine
- Ranitidine
- Ranitidine
- Ranitidine-150
- Ran-Ranitidine
- ratio-Ranitidine
- Riva-Ranitidine
- Sandoz Ranitidine
Notice of alternative medication authorization, October 2, 2019 – Minocycline hydrochloride replaces:
- Minocycline-50
- Mylan-Minocycline
- Novo-Minocycline
- pms-Minocycline
Notice of alternative medication authorization, October 2, 2019 – Minocycline hydrochloride 100 mg replaces:
- Minocycline-100
- Mylan-Minocycline
- Novo-Minocycline
- pms-Minocycline
Notice of alternative medication authorization, September 26, 2019 – Losartan potassium replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
Notice of alternative medication authorization, September 18, 2019 – Trifluoperazine hydrochloride 1 mg replaces Trifluoperazine 1 mg.
Notice of alternative medication authorization, September 16, 2019 – Losartan potassium 25 mg replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
Notice of alternative medication authorization, September 16, 2019 – Losartan potassium 50 mg replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
Notice of alternative medication authorization, September 16, 2019 – Losartan potassium 100 mg replaces:
- Apo-Losartan
- Auro-Losartan
- Bio-Losartan
- Co-Losartan
- Cozaar
- Jamp-Losartan
- Losartan
- Losartan
- Losartan
- Mar-Losartan
- Mint-Losartan
- pms-Losartan
- Ran-Losartan
- Sandoz Losartan
- Septa-Losartan
- Teva Losartan
- VAN-Losartan
Notice of alternative medication authorization, September 6, 2019 – Clotrimazole replaces Clotrimaderm 50 g
Notice of alternative medication authorization, August 22, 2019 – Nifedipine replaces Nifedipine
Notice of alternative medication authorization, August 21, 2019 – Clotrimazole replaces Clotrimaderm 25 g
Notice of alternative medication authorization, July 25, 2019 – Diazepam replaces Diastat
Notice of alternative medication authorization, July 19, 2019 – Epinephrine replaces:
- Allerject
- EpiPen
Notice of alternative medication authorization, July 12, 2019 – Ibuprofen 200 mg replaces:
- Apo-Ibuprofen
- Tablets of ibuprofen
- Jamp-Ibuprofene
Notice of alternative medication authorization, July 12, 2019 – Ibuprofen 400 mg remplaces:
- Ibuprofen
- Jamp-Ibuprofene
- Novo-Profen
Notice of alternative medication authorization, June 25, 2019 – Rifampin replaces:
- Rifadin
- Rofact 300
Notice of alternative medication authorization, June 25, 2019 – Rifampin replaces:
- Rifadin
- Rofact 150
Notice of alternative medication authorization, June 19, 2019 – Hydroxyzine hydrochloride replaces:
- Atarax
- pms-hydroxyzine
Notice of alternative medication authorization, June 18, 2019 – Ibuprofen replaces Europrofen
Notice of alternative medication authorization, June 17, 2019 – Trifluridine replaces Viroptic
Notice of alternative medication authorization, May 29, 2019 – Metoprolol tartrate replaces:
- Lopresor SR 200 mg
- Sandoz Metoprolol SR 200
Notice of alternative medication authorization, May 28, 2019 – Acarbose 75 mg replaces Glucobay
Notice of alternative medication authorization, May 28, 2019 – Acarbose 50 mg replaces Glucobay
Notice of alternative medication authorization, May 28, 2019 – Acarbose 25 mg replaces Glucobay
Notice of alternative medication authorization, May 13, 2019 – Fludrocortisone acetate 0.05 mg replaces Florinef
Notice of alternative medication authorization, May 13, 2019 – Fludrocortisone acetate 0.1 mg replaces Florinef
Notice of alternative medication authorization, April 19, 2019 – Carbamazepine replaces:
- Taro-Carbamazepine
- Tégrétol
- Teva-Carbamazepine
Notice of alternative medication authorization, March 4, 2019 – Fluvastatine sodium replaces Teva Fluvastatin
Notice of alternative medication authorization, February 21, 2019 – Chloroquine phosphate replaces Novo-Chloroquine
Notice of alternative medication authorization, February 1, 2019 – Prazosin hydrochloride replaces Novo-Prazin (1 mg).
Notice of alternative medication authorization, February 1, 2019 – Prazosin hydrochloride replaces Novo-Prazin (2 mg)
Notice of alternative medication authorization, January 30, 2019 – Tacrolimus replaces Protopic
Notice of alternative medication authorization, January 22, 2019 – Tacrolimus replaces Protopic
Notice of alternative medication authorization, January 18, 2019 – Imiquimod replaces:
- Aldara P
- Apo-Imiquimod
Notice of alternative medication authorization, January 4, 2019 – Bromazepam replaces Bromazepam-3

Notice of alternative medication authorization, December 27, 2018 – Liothyronine sodium replaces Cytomel
Notice of alternative medication authorization, December 27, 2018 – Clobazam replaces:
- Apo-Clobazam
- Frisium
Notice of alternative medication authorization, December 20, 2018 – Sulfasalazine replaces pms-Sulfasalazine-E. C.
Notice of alternative medication authorization, December 3, 2018 – Mupirocine replaces Bactroban
Notice of alternative medication authorization, December 3, 2018
- Bromazepam-6, USP (02220539)
Notice of alternative medication authorization, November 15, 2018 – Potassium chloride replaces pms-Potassium Chloride
Notice of alternative medication authorization, November 5, 2018
- Cytomel, USP (01919458)
Notice of alternative medication authorization, November 5, 2018
- Act Valsartan (02337487)
- Apo-Valsartan (02371510)
- Auro-Valsartan (02414201)
- Diovan (02270528)
- Mylan-Valsartan (02383527)
- pms-Valsartan (02312999)
- Ran-Valsartan (02363062)
- Riva-Valsartan (02425440)
- Sandoz Valsartan (02356740)
- Teva Valsartan (02356643)
- Valsartan (02367726)
- Valsartan (02366940)
- Valsartan (02384523)
- Act Valsartan (02337495)
- Apo-Valsartan (02371529)
- Auro-Valsartan (02414228)
- Diovan (02244781)
- Mylan-Valsartan (02383535)
- pms-Valsartan (02313006)
- Ran-Valsartan (02363100)
- Riva-Valsartan (02425459)
- Sandoz Valsartan (02356759)
- Teva Valsartan (02356651)
- Valsartan (02367734)
- Valsartan (02366959)
- Valsartan (02384531)
Notice of alternative medication authorization, November 1, 2018
- Novo-Chloroquine, USP (00021261)
Notice of alternative medication authorization, October 30, 2018
- Novo-Ranidine, USP (02242940)
Notice of alternative medication authorization, October 15, 2018
- Act Pramipexole, USP (02297302)
- Apo-Pramipexole, USP (02292378)
- Auro-Pramipexole, USP (02424061)
- Mirapex, USP (02237145)
- pms-Pramipexole, USP (02290111)
- Pramipexole, USP (02325802)
- Pramipexole, USP (02367602)
- Pramipexole, USP (02309122)
- Sandoz Pramipexole, USP (02315262)
- Teva-Pramipexole, USP (02269309)
- Act Pramipexole, USP (02297310)
- Apo-Pramipexole, USP (02292386)
- Auro-Pramipexole, USP (02424088)
- pms-Pramipexole, USP (02290138)
- Pramipexole, USP (02325810)
- Pramipexole, USP (02367610)
- Pramipexole, USP (02309130)
- Sandoz Pramipexole, USP (02315270)
- Teva-Pramipexole, USP (02269317)
- Act Pramipexole, USP (02297329)
- Apo-Pramipexole, USP (02292394)
- Auro-Pramipexole, USP (02424096)
- pms-Pramipexole, USP (02290146)
- Pramipexole, USP (02325829)
- Pramipexole, USP (02367629)
- Pramipexole, USP (02309149)
- Sandoz Pramipexole, USP (02315289)
- Teva-Pramipexole, USP (02269325)
Notice of alternative medication authorization, October 5, 2018
- Nifedipine, USP (00725110)
Notice of alternative medication authorization, September 28, 2018
- Act Pramipexole, USP (02297302)
- Apo-Pramipexole, USP (02292378)
- Auro-Pramipexole, USP (02424061)
- Mirapex, USP (02237145)
- pms-Pramipexole, USP (02290111)
- Pramipexole, USP (02325802)
- Pramipexole, USP (02367602)
- Pramipexole, USP (02309122)
- Sandoz Pramipexole, USP (02315262)
- Teva-Pramipexole, USP (02269309)
- Act Pramipexole, USP (02291310)
- Apo-Pramipexole, USP (02292386)
- Auro-Pramipexole, USP (02424088)
- pms-Pramipexole, USP (02290138)
- Pramipexole, USP (02325810)
- Pramipexole, USP (02367610)
- Pramipexole, USP (02309130)
- Sandoz Pramipexole, USP (02315270)
- Teva-Pramipexole, USP (02269317)
- Act-Pramipexole, USP (02297329)
- Apo-Pramipexole, USP (02292394)
- Auro-Pramipexole, USP (02424096)
- pms-Pramipexole, USP (02290146)
- Pramipexole, USP (02325829)
- Pramipexole, USP (02367629)
- Pramipexole, USP (02309149)
- Sandoz Pramipexole, USP (02315289)
- Teva-Pramipexole, USP (02269325)
Notice of alternative medication authorization, September 17, 2018
- Act Pramipexole, USP (02297302)
- Apo-Pramipexole, USP (02292378)
- Auro-Pramipexole, USP (02424061)
- Mirapex, USP (02237145)
- pms-Pramipexole, USP (02290111)
- Pramipexole, USP (02325802)
- Pramipexole, USP (02367602)
- Pramipexole, USP (02309122)
- Sandoz Pramipexole, USP (02315262)
- Teva-Pramipexole, USP (02269309)
- Act Pramipexole, USP (02297310)
- Apo-Pramipexole, USP (02292386)
- Auro-Pramipexole, USP (02424088)
- pms-Pramipexole, USP (02290138)
- Pramipexole, USP (02325810)
- Pramipexole, USP (02367610)
- Pramipexole, USP (02309130)
- Sandoz Pramipexole, USP (02315270)
- Teva-Pramipexole, USP (02269317)
- Act Pramipexole, USP (02297329)
- Apo-Pramipexole, USP (02292394)
- Auro-Pramipexole, USP (02424096)
- pms-Pramipexole, USP (02290146)
- Pramipexole, USP (02325829)
- Pramipexole, USP (02367629)
- Pramipexole, USP (02309149)
- Sandoz Pramipexole, USP (02315289)
- Teva-Pramipexole, USP (02269325)
Notice of alternative medication authorization, September 4, 2018
- Allerject, USP (02382059)
- EpiPen Jr. USP (00578657)
Notice of alternative medication authorization, September 4, 2018
- Allerject, USP (02382067)
- EpiPen, USP (00509558)
Notice of alternative medication authorization, September 1, 2018
- Erythromycin, USP (02326663)

List of medications

Note on the Regulation respecting the List of medications

Notices of end of coverage

Notices of exclusion

Notices of replacement

Recent notices

2023 notices

2022 notices

2021 notices

2020 notices

2019 notices

2018 notices

Register

2023

2022

2021

2020

2019

2018